Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 3 9Phase 2/3 5Phase 4 2Phase 1/2 2Phase NA 1

Status

Unknown 5Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Colorectal Neoplasms 1

Interventions

Cisplatin 20Docetaxel 19Capecitabine 19Oxaliplatin 14Drug Therapy 14Cyclophosphamide 14Paclitaxel 13Fluorouracil 12Radiotherapy 11apatinib 9Gemcitabine 9Doxorubicin 9Decitabine 9Methotrexate 8Epirubicin 8Carboplatin 8sintilimab 6Etoposide 6camrelizumab 5anlotinib 5XELOX 5Sorafenib 5Radiation 5Pemetrexed 5Neoadjuvant Therapy 5Leucovorin 5Idarubicin 5Dexamethasone 5Cytarabine 5Busulfan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Unknown × XELOX × Clear all
NCT03957733 2022-04-06

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

King Abdullah Medical City

Phase 2/3 Unknown
338 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03399253 2018-01-16

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Sun Yat-sen University

Phase 2/3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02777437 2016-05-19

Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer

Fudan University

Phase 2/3 Unknown
1,960 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Jiangsu Province Hospital of Traditional Chinese Medicine

Phase 2/3 Unknown
64 enrolled
Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT02510118 2015-08-03

Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients

Nanjing NingQi Medicine Science and Technology Co., Ltd.

Phase 2/3 Unknown
360 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡